Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014)

Bausch Health Companies' (BHC) quarterly Non Operating Investment Income came in at $293.0 million in Q4 2014, up 11620.0% quarter-over-quarter from $2.5 million in Q2 2014.

Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014) Analysis & Trends

Bausch Health Companies has disclosed Non Operating Investment Income across 5 years of filings, most recently posting $293.0 million for Q4 2014.

  • Non Operating Investment Income for Q4 2014 came in at $293.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was $293.0 million (down 0.85% YoY), and the FY2014 annual result was $293.0 million, up 4951.72% from the prior year.
  • Non Operating Investment Income came in at $293.0 million for Q4 2014 at Bausch Health Companies, up from $2.5 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $293.0 million in Q4 2014 to a low of -$5.0 million in Q3 2010.
  • The 5-year median for Non Operating Investment Income is $922500.0 (2011), against an average of $22.9 million.
  • Across the five-year window, Non Operating Investment Income tumbled 100.17% in 2012 and soared 11242.86% in 2013, its largest moves.
  • Bausch Health Companies' Non Operating Investment Income stood at -$5.0 million in 2010, then jumped by 99.78% to -$11000.0 in 2011, then soared by 790.91% to $76000.0 in 2012, then jumped by 5031.58% to $3.9 million in 2013, then soared by 7412.82% to $293.0 million in 2014.
  • The last three Non Operating Investment Income figures came in at $293.0 million (Q4 2014), $2.5 million (Q2 2014), and $3.9 million (Q2 2013), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -
10 Bausch Health Companies 1.92 Bn 1.58 Bn 2.48 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2014 293.00 Mn
Dec 31, 2014 293.00 Mn
Jun 30, 2014 2.50 Mn
Jun 30, 2014 2.50 Mn
Jun 30, 2013 3.90 Mn
Jun 30, 2013 3.90 Mn
Mar 31, 2013 1.86 Mn
Mar 31, 2013 1.86 Mn
Dec 31, 2012 76,000.00
Dec 31, 2012 76,000.00
Jun 30, 2012 -35,000.00
Jun 30, 2012 -35,000.00
Mar 31, 2012 2.06 Mn
Mar 31, 2012 2.06 Mn
Dec 31, 2011 -11,000.00
Dec 31, 2011 -11,000.00
Sep 30, 2011 -140,000.00
Sep 30, 2011 -140,000.00
Jun 30, 2011 21.16 Mn
Jun 30, 2011 21.16 Mn